Cologuard Garners Another FDA Approval
The U.S. Food and Drug Administration approved Exact Sciences‘ Cologuard for use by eligible average-risk individuals ages 45 and older, the company announced today. Previously, the FDA had approved use…
The U.S. Food and Drug Administration approved Exact Sciences‘ Cologuard for use by eligible average-risk individuals ages 45 and older, the company announced today. Previously, the FDA had approved use…
FUJIFILM Cellular Dynamics (FCDI) today unveiled its new 32,000-sq.ft. cell therapeutics facility at 465 Science Dr. that has been named i-FACT (Innovation Facility for Advanced Cell Therapies). It marked a milestone…
SHINE Medical Technologies added former House Speaker Paul Ryan to its board of directors, the company announced recently. “Paul is a visionary with a wealth of experience and an expansive…
NorthStar Medical Radioisotopes and Purdue University’s College of Pharmacy signed a collaborative agreement, which expands the College of Pharmacy’s nuclear pharmacy training program, the company announced recently. “We are excited…
SHINE Medical Technologies received a $15 million award from the Department of Energy’s National Nuclear Security Administration (DOE/NNSA), the company announced today. “We are grateful for DOE/NNSA’s award as SHINE continues…
Primorigen Biosciences has been acquired by Nucleus Biologics, a leader in precision cell culture, the company announced today. “The exceptionally strong fit of the Nucleus and Primorigen product portfolios provide…
Exact Sciences will acquire Genomic Health, a provider of genomic-based diagnostic tests that help optimize cancer care, in a cash and stock transaction valued at $2.8 billion, the company announced today. According to…
NorthStar Medical Radioisotopes has been awarded $15 million in a cooperative agreement with the U.S. Department of Energy’s National Nuclear Security Administration (DOE/NNSA), the company announced today. According to a…
SHINE Medical Technologies has filed an application with the U.S. Nuclear Regulatory Commission to produce medical isotopes at its production facility in Janesville, Wis., the company announced today. “Completing our…
FUJIFILM Cellular Dynamics and Axcelead Drug Discovery Partners are collaborating to provide customers with a human induced pluripotent stem cell (iPSC)-based integrated platform for drug discovery solutions, the company announced recently….